Whitehawk Therapeutics Inc
public_traded
Whitehawk Therapeutics Inc is publicly traded on NASDAQ under ticker WHWK.
Whitehawk Therapeutics Inc operates as a clinical-stage biopharmaceutical company. The Company develops precision therapies for genetically-defined cancers.